Patents
Patents for C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325)
02/2007
02/27/2007US7183286 Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (BVDV) infection and hepatitis C virus (HCV) infection
02/27/2007US7183279 Synergistic combinations with morphine; analgesics and cyclooxygenase-2 inhibitors, such as N-5-guanidinopentanamide-(2S)-yl-2-N-(p-hydroxyphenylacetyl)phenylenediamine and N-5-guanidinopentanamide-(2R)-yl-2-N-(p-hydroxybenzyl)-5-carboxybenzimidazole
02/22/2007WO2007020659A2 A process for the preparation of irbesartan form a
02/22/2007US20070043219 Cis and trans configurations of these chemical intermediates for insecticides, miticides, and herbicides or drugs; prepared using water as solvent to form a hydrolyzable spirohydantoin from a 4-alkylcyclohexanone
02/22/2007US20070043043 Benzimidazole derivates: preparation and pharmaceutical applications
02/22/2007CA2618634A1 Compounds and compositions as tpo mimetics
02/21/2007EP1754475A1 Use of C-terminal modified oxamyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases
02/21/2007EP1753740A2 Amino cyclopentyl heterocyclic and carbocyclic modulators of chemokine receptor activity
02/21/2007EP1753730A1 Dipeptidyl peptidase inhibitors
02/21/2007EP1753713A2 Synthesis of tetracyclines and analogues thereof
02/21/2007EP1311482B1 Non-imidazole aryloxypiperidines as h3 receptor ligands
02/21/2007EP1135374B9 Benzimidazole compounds that are vitronectin receptor antagonists
02/21/2007CN1918161A Tricyclic imidazopyridines and intermediates for the synthesis thereof
02/21/2007CN1918151A Tricyclic steroid hormone nuclear receptor modulators
02/21/2007CN1918146A Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication
02/21/2007CN1918131A Novel inhibitors of glutaminyl cyclase
02/21/2007CN1918118A Thioamide compound or its salt and cytokine production inhibitor containing the same
02/21/2007CN1301255C Inhibitors of alpha l beta 2 integrin mediated cell adhesion
02/21/2007CN1301250C Benzoxazole and benzodiazole UV-A sunscreens
02/20/2007US7179912 Materials and methods to potentiate cancer treatment
02/20/2007US7179839 For therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction
02/20/2007US7179832 Glycogen synthase kinase 3β inhibitor, composition and process for the preparation thereof
02/20/2007US7179829 Such as trans-(2-chloro-6-trifluoromethylphenyl)-(octahydrobenzimidazol-2-ylidene)amine hydrochloride; for treatment/prophylaxis of central nervous system disorders, lipid metabolism, infection by ectoparasites, disorders of gall function, improving respiratory drive/snoring
02/20/2007US7179817 For therapy and prophylaxis of peripheral arterial disease such as arteriosclerosis obliterans, thromboangiitis obliterans, Buerger's disease or diabetic neuropathy, sepsis, angiitis, nephritis, pneumonia, stroke, myocardial infarction, edematous state, atherosclerosis, varicosity such as hemorrhoid
02/20/2007US7179794 Antibiotics; bactericides
02/20/2007CA2371174C Cyclo-alkyl substituted benzimidazoles and their use as parp inhibitors
02/15/2007WO2007019416A1 Benzimidazole derivatives as sirtuin modulators
02/15/2007WO2007018067A1 Transition metal complex compound and organic electroluminescent device using same
02/15/2007WO2007018007A1 Nitrogenous heterocyclic derivative and organic electroluminescence device making use of the same
02/15/2007WO2007017267A2 Novel compounds
02/15/2007US20070037803 Benzimidazole derivatives
02/15/2007US20070037788 5-(3,8-Difluoro-6H-dibenzo[b,e]oxepin-11-ylidenemethyl)-1-(1-ethyl-pyrrolidin-3-yl) -1,3-dihydro-benzoimidazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia
02/15/2007CA2617557A1 Benzimidazole derivatives as sirtuin modulators
02/15/2007CA2607219A1 Substituted benzimidazole compounds with dual nos inhibitory activity and mu opioid agonist activity
02/14/2007EP1752452A1 Propane-1,3-dione derivative or its salt
02/14/2007EP1751114A2 Factor viia inhibitor
02/14/2007EP1751097A1 Substituted n-aryl benzamides and related compounds for treatment of amyloid diseases and synucleinopathies
02/14/2007EP1560828B9 Imidazoquinoline derivatives as adenosine a3 receptor ligands
02/14/2007CN1914196A 5- or 6-substituted benzimidazole derivatives as inhibitors of respiratiory syncytial virus replication
02/14/2007CN1913886A 杂环天冬氨酰蛋白酶抑制剂 Heterocyclic aspartyl protease inhibitors
02/14/2007CN1913880A Method for treating ADAMTS-5-associated disease
02/14/2007CN1300143C Temozolomide refining process
02/14/2007CN1300110C Hydroxamate derives useful as deacetylase inhibitors
02/13/2007US7176322 Bone disorders; hyperparathyroidism; such as N-((1-ethyl-3-phenyl-1H-indol-5-yl)methyl)-1-phenylethanamine
02/13/2007US7176223 5-(3-Pyridylmethyl)imidazolidine-2,4-dione is subjected to a hydrolysis reaction, wherein the reaction is followed by a decarbamation reaction to obtain (3-pyridyl)alanine
02/08/2007WO2007015805A1 1-amino linked compounds
02/08/2007WO2007014846A1 Novel benzimidazole (thio) carbamates with antiparasitic activity and the synthesis thereof
02/08/2007WO2007014608A1 Quadratic acid ii derivatives
02/08/2007WO2006110477A3 Compounds to treat amyloidosis and prevent death of beta-cells in type 2 diabetes mellitus
02/08/2007US20070032536 Compounds, compositions and methods
02/08/2007US20070032497 Fused-ring compounds and use thereof as drugs
02/08/2007CA2616669A1 Squaric acid derivatives_ii
02/08/2007CA2616512A1 Novel benzimidazole (thio) carbamates with antiparasitic activity and the synthesis thereof
02/07/2007EP1748990A1 Process for the preparation of telmisartan
02/07/2007EP1656348B1 Acetylene derivatives as inhibitors of histone deacetylase
02/07/2007EP1017680B1 Tricyclic compounds, preparation method and said method intermediates, application as medicines and pharmaceutical compositions containing same
02/07/2007CN1910164A Organic compounds
02/07/2007CN1907991A Preparation of arginine lyase model compound and application thereof
02/07/2007CN1298720C Sinomenine derivative with C cycle connected to penetabasic heterocycle and synthesizing method
02/07/2007CN1298707C Imidazole and benzimiddzole caspase inhibitors and uses thereof
02/06/2007US7173053 effective against the growing number of resistant bacteria, particularly the vancomycin resistant enterococci and beta -lactam antibiotic-resistant bacteria, such as methicillin-resistant Staphylococcus aureus
02/06/2007US7173039 Compounds that modulate or inhibit enzymes for occular diseases
02/01/2007WO2007013101A1 PROCESS FOR PRODUCING 2-(N-BUTYL)-3-[[2'-(TETRAZOL-5-YL)BIPHENYL- 4-YL]METHYL]-l,3-DIAZASPIRO[4.4] NON-1-EN-4-ONE
02/01/2007WO2006086255A3 Inhibitors of checkpoint kinases
02/01/2007US20070027200 Bis-benzimidazoles and related compounds as potassium channel modulators
02/01/2007US20070027158 High affinity small molecule C5a receptor modulators
02/01/2007DE102005035742A1 New cyclobut-3-ene-1,2-dione derivatives are kinase inhibitors useful for treating e.g. cancer, hypertension, diabetes, glaucoma and bacterial infections
01/2007
01/31/2007EP1746888A2 Compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases
01/31/2007CN1906190A 选择性激酶抑制剂 Selective kinase inhibitor
01/31/2007CN1906174A Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament
01/31/2007CN1297554C Amido ether substituted imidazoquinolines
01/31/2007CN1297544C 2-phenyl benzoimidazole-5-sulfonic acid prepared with segregative 3.4-diaminobenzene sulfonic and its application in cosmetics production
01/30/2007US7169934 (R) 2-(4-amidinophenylaminomethyl)-1-methyl-5-[1-(carboxymethylamino)-1 (pyrrolidinocarbonyl)-ethyl]-benzimidazole, the monohydrochloride thereof, preparation thereof and the use as pharmaceutical composition
01/30/2007US7169801 Antiinflammatory agents; inflammatory bowel disorders; capable of complexing with a deacetylase catalytic site and/or a metal ion
01/25/2007WO2007011170A1 New imidazole derivatives, preparation method thereof and organic electronic device using the same
01/25/2007WO2007010653A1 Salt molten at room temperature and display device
01/25/2007WO2007010558A1 A process for the preparation of telmisartan
01/25/2007WO2007009967A1 Preparation of 1,7′-dimethyl-2′-propyl-2,5′-bi-1h-benzimidazole
01/25/2007WO2007009774A1 Benzimidazole derivatives for treatment of inflammatory diseases
01/25/2007WO2006125592A3 Process for the preparation of 2-alkyl-1-((2'-substituted-biphenyl-4-yl)methyl)-imidazole, dihydroimidazole or benzimidazole derivatives
01/25/2007WO2006050921A3 Preparation of telmisartan salts with improved solubility
01/25/2007US20070021482 1,5,7-Trisubstituted benzimidazole derivatives and their use for modulating the gabaa receptor complex
01/25/2007US20070021474 Heterocyclically Substituted Benzoylureas, Process For Their Preparation and Their Use as Pharmaceuticals
01/25/2007US20070021456 Aminobenzimidazole derivatives
01/25/2007US20070021426 Derivatives of heteroaryl-alkylcarbamates, methods for their preparation and use thereof as fatty acid amido hydrolase enzyme inhibitors
01/25/2007US20070021386 Azole derivatives and fused bicyclic azole derivatives as therapeutic agents
01/25/2007US20070018155 New imidazole derivatives, preparation method thereof and organic electronic device using the same
01/25/2007US20070018154 Imidazole derivatives and organic electronic device using the same
01/25/2007DE102005034279A1 Herstellung von 1,7'-Dimethyl-2'-propyl-2,5'-bi-1H-benzimidazol Preparation of 1,7'-dimethyl-2'-propyl-2,5'-bi-1H-benzimidazole
01/25/2007CA2615746A1 Preparation of 1,7'-dimethyl-2'-propyl-2,5'-bi-1h-benzimidazole
01/25/2007CA2615381A1 Synergistic composition and method for inhibiting growth of microorganisms
01/25/2007CA2612469A1 Benzimidazole derivatives for treatment of inflammatory diseases
01/24/2007CN1902322A Optically active, heteroaromatic beta-hydroxy esters, processes for their preparation from beta-keto esters and processes for the preparation of these beta-keto esters
01/24/2007CN1902200A 1h-imidazoquinoline derivatives as protein kinase inhibitors
01/24/2007CN1902181A Benzimidazoles useful as modulators of ion channels
01/24/2007CN1902171A Benzylether amine compounds useful as CCR-5 antagonists
01/24/2007CN1900077A New polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations
01/24/2007CN1900067A Tricyclic compounds, their production and use
01/24/2007CN1900065A Process synthesizing methyl mercapto benizmidazole by using TDI byproducts
01/24/2007CN1296346C Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical
1 ... 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 ... 154